Profil
Mary Gardner is associated with DelNova, Inc. as the Chief Executive Officer & Director since 2016.
She is the founder of DelNova, Inc. which was founded in 2016.
Postes actifs de Mary Gardner
| Sociétés | Poste | Début |
|---|---|---|
DelNova, Inc.
 DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Fondateur | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
DelNova, Inc.
DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Health Technology |
